Topical Oral Probiotic Lipid Formulations for Skin Eubiosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively maintain and enhance eubiosis on the skin, leading to issues like inflammation, irritation, and skin diseases due to imbalances in the skin microbiota, such as eczema, atopic dermatitis, and acne vulgaris.
Innovation Solution
A topical and oral probiotic product combination that includes a synergistic blend of prebiotic lipids and probiotic bacteria, specifically designed to colonize the skin and promote healthy skin microbiota, using a blend of oils and natural waxes to approximate the skin's natural lipid layer and incorporating strains like Bacillus licheniformis, Bifidobacterium, and Lactobacillus to restore balance and inhibit pathogenic organisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional skin care methods are used, then basic skin maintenance is achieved, but they fail to effectively maintain and enhance eubiosis, leading to inflammation and skin diseases
Solution Approach 1:
The patent combines multiple probiotic bacterial strains (Staphylococcus epidermidis, Lactobacillus, Bifidobacterium, Bacillus) with prebiotic lipids and skin-conditioning agents in a unified topical formulation. This combination creates a synergistic effect that simultaneously colonizes the skin with beneficial microbes, provides lipid support for barrier function, and reduces inflammation, thereby effectively maintaining eubiosis and preventing skin diseases.
Solution Approach 2:
The formulation uses a composite approach by integrating living probiotic bacteria with prebiotic lipids (ceramides, cholesterol, fatty acids) and skin-conditioning agents. This composite formulation creates a multi-functional system that supports microbial colonization, maintains skin barrier integrity, and provides anti-inflammatory effects, addressing the limitations of single-component conventional treatments.
2Object-generated harmful factors
If the skin microbiota is left unbalanced, then natural skin functions are maintained, but pathogenic organisms take up residency causing dysbiosis and skin conditions
Solution Approach 1:
The formulation takes preliminary anti-action by introducing beneficial probiotic strains before pathogenic organisms can establish themselves. The prebiotic lipids and probiotic bacteria work together to preemptively colonize the skin surface, creating a protective microbial ecosystem that prevents pathogenic invasion and maintains microbiota balance.
Solution Approach 2:
The formulation leverages the self-service mechanism of the skin microbiota by providing the necessary nutrients (prebiotic lipids) and beneficial organisms (probiotics) that enable the skin's own microbial community to maintain balance and regulate itself, rather than requiring external intervention to correct dysbiosis.
3Quantity of substance
If probiotic bacteria are applied topically, then skin colonization occurs, but the formulation must be stable enough to sustain the organisms while remaining effective
Solution Approach 1:
The prebiotic lipids serve as an intermediary substance that facilitates the survival and stability of probiotic bacteria in the formulation. These lipids provide a protective matrix that maintains bacterial viability while allowing the formulation to remain stable during storage and application, solving the contradiction between organism sustainability and formulation stability.
Solution Approach 2:
The formulation optimizes parameters such as pH, lipid composition, and bacterial strain selection to create conditions that favor both stability and viability. By carefully controlling these parameters, the formulation maintains probiotic organisms in a stable, viable state throughout the product lifecycle while ensuring effectiveness upon application.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The product effectively maintains and enhances eubiosis, improving skin health by sustaining probiotic organisms, reducing acne, and correcting dysbiosis, as demonstrated by increased skin hydration, improved texture, and reduced symptoms of skin conditions like atopic dermatitis and rosacea.
Implementation Method 1
S. epidermidis produces a variety of molecules that have antimicrobial activity. For example, peptides called phenosoluble modulins demonstrate selective activity against S. aureus, group A Streptococci, and Escherichia coli
Implementation Method 2
The product effectively maintains and enhances eubiosis, improving skin health by sustaining probiotic organisms, reducing acne, and correcting dysbiosis
Implementation Method 3
using a blend of oils and natural waxes to approximate the skin's natural lipid layer
Implementation Method 4
colonization with S. epidermidis induces IL-17A+ CD8+ T cells that are normally found on the epidermis and help enhance innate barrier immunity and limit pathogen invasion
Data Source
AI summary
A system for treating and maintaining the health of the skin of a user. The system may include a topical formulation and an oral formulation. The topical formation may include various probiotic organisms selected for enhancing and treating the skin of a user. The oral formulation may include various probiotic organisms for enhancing and treating the skin of the user. The topical formulation and the oral formulation may be used cooperatively and simultaneously to produce a beneficial, synergistic effect.